X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6877) 6877
Book Review (848) 848
Publication (314) 314
Book Chapter (96) 96
Conference Proceeding (43) 43
Dissertation (36) 36
Reference (11) 11
Government Document (5) 5
Book / eBook (3) 3
Magazine Article (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
l-dopa (5532) 5532
index medicus (4345) 4345
animals (2308) 2308
humans (2275) 2275
male (2186) 2186
parkinson's disease (2164) 2164
neurosciences (2117) 2117
female (1366) 1366
clinical neurology (1329) 1329
rats (1269) 1269
parkinsons-disease (1206) 1206
dopamine (1135) 1135
levodopa (1077) 1077
pharmacology & pharmacy (973) 973
parkinson disease - drug therapy (967) 967
levodopa - pharmacology (852) 852
middle aged (847) 847
aged (763) 763
levodopa - therapeutic use (698) 698
dopa (608) 608
dopamine - metabolism (604) 604
basal ganglia (542) 542
brain (517) 517
adult (515) 515
biochemistry & molecular biology (508) 508
mice (491) 491
antiparkinson agents - therapeutic use (490) 490
levodopa - adverse effects (484) 484
dyskinesia (470) 470
rats, sprague-dawley (468) 468
parkinson disease - physiopathology (461) 461
neurology (434) 434
phenols (420) 420
disease models, animal (412) 412
dose-response relationship, drug (408) 408
striatum (402) 402
analysis (382) 382
time factors (374) 374
neurons (373) 373
parkinson’s disease (366) 366
levodopa - administration & dosage (357) 357
antiparkinson agents - adverse effects (352) 352
substantia-nigra (342) 342
motor activity - drug effects (330) 330
double-blind (329) 329
motor fluctuations (323) 323
psychiatry (316) 316
corpus striatum - drug effects (311) 311
corpus striatum - metabolism (308) 308
parkinsons disease (308) 308
rats, wistar (298) 298
metabolism (287) 287
antiparkinson agents - pharmacology (282) 282
oxidative stress (279) 279
parkinson disease - metabolism (278) 278
rat (278) 278
serotonin (277) 277
6-hydroxydopamine (276) 276
mptp (268) 268
disease (262) 262
levodopa - metabolism (260) 260
movement disorders (251) 251
therapy (235) 235
brain - metabolism (234) 234
carbidopa (232) 232
levodopa - pharmacokinetics (227) 227
dopamine agents - pharmacology (220) 220
expression (214) 214
pharmacokinetics (212) 212
antiparkinson agents - administration & dosage (206) 206
parkinson disease - complications (203) 203
positron emission tomography (201) 201
abridged index medicus (199) 199
chemistry, analytical (196) 196
behavior, animal - drug effects (195) 195
treatment outcome (188) 188
apomorphine (187) 187
oxidopamine (187) 187
aged, 80 and over (184) 184
catecholamines (182) 182
levodopa-induced dyskinesia (182) 182
neurons - drug effects (182) 182
parkinsonian disorders - drug therapy (182) 182
microdialysis (175) 175
article (174) 174
brain - drug effects (173) 173
levodopa-induced dyskinesias (170) 170
mice, inbred c57bl (169) 169
amino-acid decarboxylase (168) 168
analysis of variance (168) 168
kinetics (167) 167
tyrosine 3-monooxygenase - metabolism (165) 165
tyrosine (164) 164
in-vivo (161) 161
restless legs syndrome (161) 161
immunohistochemistry (160) 160
inhibition (158) 158
parkinson disease - therapy (158) 158
rat-brain (157) 157
dopaminergic-neurons (155) 155
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6671) 6671
German (130) 130
French (57) 57
Spanish (53) 53
Japanese (52) 52
Chinese (28) 28
Korean (19) 19
Russian (12) 12
Portuguese (10) 10
Italian (7) 7
Czech (5) 5
Turkish (4) 4
Polish (3) 3
Slovak (2) 2
Croatian (1) 1
Malay (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Parkinsonism & related disorders, ISSN 1353-8020, 05/2019
L-dopa responsiveness in Parkinson's disease (PD) varies, but the clinical correlates and significance of this are ill-defined. Patients were assessed before... 
Journal Article
Neuroscience Letters, ISSN 0304-3940, 08/2016, Volume 628, pp. 225 - 229
One of the intermediates of methionine cycle, the homocysteine (Hcy), elevates in plasma of Parkinson’s disease (PD) patients undergoing L-DOPA... 
Dopaminergic neurons | Hyperhomocysteinemia | L-DOPA
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 07/2018, Volume 347, pp. 175 - 183
L-DOPA-induced dyskinesia (LID) is a frequent complication of chronic L-DOPA therapy in the clinical treatment of Parkinson’s disease (PD). The pathogenesis of... 
Metabolomics | Striatum | Parkinson’s disease | L-DOPA | Dyskinesia
Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 12/2016, Volume 33, pp. S1 - S1
Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 12/2016, Volume 33, p. S1
Journal Article
Neuropharmacology, ISSN 0028-3908, 04/2014, Volume 79, pp. 90 - 100
The molecular basis of priming for -DOPA-induced dyskinesias in Parkinson's disease (PD), which depends on the indirect pathway of motor control, is not known.... 
Striatum | Caudate | Dopamine | Parkinson's disease | l-Dopa | Receptor heteromer | Putamen
Journal Article
Pharmaceutical Biology, ISSN 1388-0209, 01/2019, Volume 57, Issue 1, pp. 355 - 362
Context: Parkinson's disease (PD) is a neurodegenerative disorder due to gradual loss of dopaminergic nerves in the substantia nigra (SN) in the midbrain. PD... 
Ginkgo biloba | Dopaminergic receptors | L-DOPA | curcumin
Journal Article
Movement Disorders, ISSN 0885-3185, 2008, Volume 23, Issue 3, pp. S570 - S579
Journal Article
Physiology & Behavior, ISSN 0031-9384, 05/2018, Volume 188, pp. 108 - 118
Our aim was to assess the effect of different doses of linagliptin with or without -dopa/Carbidopa on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine... 
Parkinsonism | l-dopa | Behavioural changes | Linagliptin | Mice | Carbidopa | L-dopa | Index Medicus
Journal Article
Pharmacology Biochemistry and Behavior, ISSN 0091-3057, 2014, Volume 124, pp. 204 - 210
Parkinson's disease (PD) drug therapy remains a challenge. Dual modulation of dopamine and 5-HT receptors has emerged as a promising approach in anti-PD drug... 
Parkinson disease | L-DOPA-induced dyskinesia
Journal Article
ANNALS OF NEUROLOGY, ISSN 0364-5134, 03/2008, Volume 63, Issue 3, pp. 295 - 302
Objective: Based on new understanding of nondopaminergic pathways involved in Parkinson's disease (PD) pathophysiology, a selective adenosine A(2A) receptor... 
MOTOR FLUCTUATIONS | DIAGNOSIS | RAT | L-DOPA | DYSKINESIA | BLOCKADE | NEUROSCIENCES | CLINICAL NEUROLOGY | LEVODOPA
Journal Article
Neuroscience and Biobehavioral Reviews, ISSN 0149-7634, 09/2018, Volume 92, pp. 67 - 82
Traditionally, dopamine (DA) and acetylcholine (ACh) striatal systems were considered antagonistic and imbalances or aberrant signaling between these... 
Striatum | Dopamine | L-DOPA | Acetylcholine | Cholinergic interneurons | Parkinson’s disease | Dyskinesia
Journal Article
Neuropharmacology, ISSN 0028-3908, 06/2015, Volume 97, pp. 306 - 311
l-3,4-dihydroxyphenylalanine (l-DOPA) is the most effective anti-parkinsonian agent available, but upon chronic administration, patients with Parkinson's... 
F15599 | L-DOPA | MPTP-lesioned macaque | On-time | Dyskinesia
Journal Article
Biophysical Chemistry, ISSN 0301-4622, 10/2019, Volume 253, pp. 106241 - 106241
Micro graphitic – diamond – multi electrode arrays (μG-D-MEAs) are suitable for measuring multisite quantal dopamine (DA) release from PC12 cells. Following... 
Dopamine | Diamond MEA | Secretion | L-Dopa | PC12 cells | Index Medicus
Journal Article
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, ISSN 1997-7298, 2018, Volume 118, Issue 6, pp. 95 - 98
Journal Article
Movement disorders : official journal of the Movement Disorder Society, ISSN 0885-3185, 11/2017, Volume 32, Issue 11, pp. 1547 - 1556
Journal Article
Expert Opinion on Drug Discovery, ISSN 1746-0441, 04/2018, Volume 13, Issue 4, pp. 295 - 305
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.